Drug Royalty III

Overview of Drug Royalty III

Drug Royalty III is a closed private equity fund managed by DRI Capital.

USD 1,450m
Fund performance

Performance data for Drug Royalty III

View performance
Fund benchmark

Benchmark for Drug Royalty III

Benchmark this fund
Secondary marketplace

Drug Royalty III in the secondaries market

Go to the marketplace
DRI Capital logo

About DRI Capital

DRI Capital is a private equity general partner firm headquartered in Toronto, ON, Canada.

View full profile

Funds managed by DRI Capital

Closed and liquidated funds managed by DRI Capital:
Fund name Size Vintage Status
Drug Royalty III USD 1,450m 2013 Closed
Drug Royalty II USD 701m 2010 Closed
Royalty II Co-Investment Fund USD 225m 2010 Closed
Drug Royalty I USD 800m 2006 Closed
Discover where LPs go for (more) PE and GPs get an inside edge
  • Access a comprehensive set of global fundraisings
  • Analyze 20,000 funds and promote your own
  • Contact LPs and GPs around the world
Join now

Registration is fast, free and easy

Already a member? Sign in